Hot off the press 🗞️ Upregulation of intracellular cAMP triggers migraine-like headache in people with post-traumatic headache 🧠 Could targeting cAMP-dependent signaling be the key to pain relief? 🧐🧠 Read more here: …alofheadacheandpain.biomedcentral.com/articles/10.11… Hakan Ashina Haidar Al-Khazali

🚀 Exciting News! Can blocking CGRP improve rosacea symptoms? Check out this study on erenumab's effectiveness in reducing flushing and erythema in #rosacea patients. International Headache Society⁩ ⁦JAMA Dermatology⁩ ⁦AAD⁩ ⁦EADV⁩ ⁦⁦Human Migraine Research Unit⁩ jamanetwork.com/journals/jamad…

🧠 New Insights Alert! 🧠 Discover how migraine reshapes the brain! Differences in Cortical Morphology in People With and Without Migraine. International Headache Society⁩ ⁦Lundbeckfonden⁩ ⁦European Headache Federation⁩ ⁦Rigshospitalet⁩ ⁦⁦American Migraine Foundation⁩ neurology.org/doi/10.1212/WN…

Leading researcher Messoud Ashina explains what #PACAP is, its role in migraine pathophysiology, how it differs from #CGRP, and its potential as a target for #migraine and other #headache disorders. Watch the full video or the transcript at migrainedisorders.org/podcast/s6ep5-…

🧠💊 New study: a non-vascular KATP channel opener doesn’t trigger migraine attacks! This suggests targeting 👉vascular 👈KATP channels may be key for migraine treatment. 🚫🤕⁦International Headache Society⁩ ⁦Lundbeckfonden⁩ ⁦European Headache Federation⁩ journals.sagepub.com/doi/10.1177/03…

Comprehensive review on Trigeminal Neuralgia in Nature Reviews Disease Primers highlights complex pathophysiology, diagnosis, & treatment challenges, effect on quality of life with variable incidence, genetic factors, & diverse treatment approaches #TrigeminalNeuralgia👇 rb.gy/phcni4

I am deeply honored and grateful to have been elected as a member of the Royal Danish Academy of Sciences and Letters. I look forward to contributing to this esteemed institution and advancing scientific research in 🇩🇰. 🙏 for this incredible recognition. royalacademy.dk/da/Aktuelt/Nye…

Saturday news 🗞️ New study in Cephalalgia reveals migraine attack induction via cGMP-dependent signaling can occur even during #CGRP receptor blockade using #erenumab🧠 Read more: journals.sagepub.com/doi/10.1177/03… Bianca Raffaelli Messoud Ashina Hakan Ashina

Dr. T Monteith talks with Dr. M Ashina about the comparison btw cortical morphometry to a large sample of people with migraine and healthy controls, as well as across migraine subtypes.⁦Teshamae Monteith, M.D.⁩ ⁦⁦American Academy of Neurology⁩ ⁩ ⁦European Academy of Neurology⁩ podcasts.apple.com/dk/podcast/neu…

🔬 New research paper finds hypersensitivity to BKCa channel opening in people with post-traumatic headache🧠 Targeting BKCa channels might open new avenues for drug discovery 💊Hakan Ashina Haidar Al-Khazali Basit Ali Chaudhry Read more here: …alofheadacheandpain.biomedcentral.com/articles/10.11…

Activation of the Kir6.2/SUR1 channel doesn't trigger migraine, suggesting it isn't involved in migraine. Study indicate that KATP channel blockers targeting Kir6.1/SUR2B in cerebral blood vessels could be new treatments. doi.pulse.ly/ajxqswgc2y Lili Kokoti Messoud Ashina Faisal Mohammad Amin

Join Nina Riggins, our Social Media Editor, as she sits down with Professor Messoud Ashina to discuss his groundbreaking paper recently published in Cephalalgia. Interview youtu.pulse.ly/v4trjp6c3u Paper journals.sagepub.com/doi/10.1177/03…

🎉 Great news for children & adolescents! 🎉 Teva's Phase 3 SPACE trial shows fremanezumab significantly reduces monthly migraine days for kids aged 6-17! 🧒👧 Safe and effective with no new safety signals. 🌟 ⁦Human Migraine Research Unit⁩ ⁦International Headache Society⁩ businesswire.com/news/home/2024…

Breaking News "International Headache Society global practice recommendations for the acute pharmacological treatment of migraine" is published. Visit the link to access the paper sagepub.pulse.ly/tc1mcru8wg #headache #migraine #guideline

Rogelio has completed his PhD fellowship at ⁦⁦Human Migraine Research Unit⁩ . After 3 years of dedicated work in our lab, he is returning to Mexico to continue his career as a neurologist. We wish him all the best in his future endeavors! ⁦🇩🇰❤️🇲🇽

Congratulations to ⁦Hashmat Ghanizada, MD, PhD⁩ on completing his postdoc BRIDGE program! 🎉 This is a significant milestone in his career. Wishing him continued success in all his future endeavors! 🙏🎗️to ⁦Novo Nordisk Foundation⁩ ⁦⁦UCPH SUND R&I⁩ ⁦

Levcromakalim does not induce migraine aura in participants with aura without headache. It likely induces migraine aura via effects on the trigeminovascular system rather than induction of CSD. journals.sagepub.com/doi/10.1177/03… Human Migraine Research Unit Messoud Ashina Mohammad Al-Mahdi Anders Hougaard

🚨 New hope for people with migraine! A Phase 2 study shows that a monoclonal antibody against PACAP reduces migraine days. 🌟⁦⁦Rigshospitalet⁩ ⁦⁦⁦International Headache Society⁩ ⁦Lundbeckfonden⁩ ⁦Human Migraine Research Unit⁩ ⁦European Headache Federation⁩ nejm.org/doi/full/10.10…

🧠The signaling molecule PACAP plays a key role in triggering migraine attacks. Discover how PACAP could reshape migraine treatment and bring relief to those in need 💡👇⁦Human Migraine Research Unit⁩ ⁦International Headache Society⁩ ⁦European Academy of Neurology⁩ ⁦European Headache Federation⁩ nature.com/articles/s4158…

Neurology Podcast: Dr. Tesha Monteith & Dr. Messoud Ashina discuss the biology of PACAP, its significance in relation to #migraines, and its potential as a novel therapeutic approach. Listen now: bit.ly/3AXNRqq Messoud Ashina Teshamae Monteith, M.D.